Clinical trials
Glioma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
164 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 8 |
| 2013 | 3 |
| 2014 | 8 |
| 2015 | 6 |
| 2016 | 14 |
| 2017 | 4 |
| 2018 | 17 |
| 2019 | 8 |
| 2020 | 13 |
| 2021 | 16 |
| 2022 | 18 |
| 2023 | 11 |
| 2024 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 164 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Huashan Hospital | 10 |
| Beijing Neurosurgical Institute | 9 |
| Beijing Tiantan Hospital | 6 |
| Peking Union Medical College Hospital | 6 |
| Assistance Publique - Hôpitaux de Paris | 4 |
| Sun Yat-sen University | 4 |
| AHS Cancer Control Alberta | 3 |
| Assistance Publique Hopitaux De Marseille | 3 |
| Hebei Yanda Hospital | 3 |
| Kentuckiana Cancer Institute | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 164 |
| Glioblastoma | 43 |
| Brain Neoplasms | 28 |
| Astrocytoma | 18 |
| Neoplasms | 10 |
| Oligodendroglioma | 10 |
| Central Nervous System Neoplasms | 6 |
| Gliosarcoma | 6 |
| Breast Neoplasms | 4 |
| Neoplasms, Neuroepithelial | 4 |
Trials
Showing 51 to 75 of 164. Each trial links to its page on Pharma Observatory.
64 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.